Henrike E. Peters

The cardiovascular risk profile of middle‐aged women with polycystic ovary syndrome

Cindy Meun, Marlise N. Gunning, Yvonne V. Louwers et al. · Clinical Endocrinology · 2019 · 63 citations · Full text

Medicine, Endocrinology, Reproductive Endocrinology +13

The FOAM study: is Hysterosalpingo foam sonography (HyFoSy) a cost-effective alternative for hysterosalpingography (HSG) in assessing tubal patency in subfertile women? Study protocol for a randomized controlled trial

Joukje van Rijswijk, Nienke van Welie, Kim Dreyer et al. · BMC Women s Health · 2018 · 36 citations · Full text

Medicine, Gynecology, Obstetrics +10

Gestational surrogacy: results of 10 years of experience in the Netherlands

Henrike E. Peters, R. Schats, Marieke O. Verhoeven et al. · Reproductive BioMedicine Online · 2018 · 33 citations

Medicine, Gynecology, Obstetrics +7

Anthropometric biomarkers for abnormal prenatal reproductive hormone exposure in women with Mayer-Rokitanksy-Küster-Hauser syndrome, polycystic ovary syndrome, and endometriosis

Henrike E. Peters, Claire H.C. Laeven, Constantia J.M.A. Trimbos et al. · Fertility and Sterility · 2020 · 23 citations

Medicine, Endocrinology, Gynecology +14

Anti-Müllerian Hormone Levels in Adolescence in Relation to Long-term Follow-up for Presence of Polycystic Ovary Syndrome

Mirte R. Caanen, Henrike E. Peters, Peter M. van de Ven et al. · The Journal of Clinical Endocrinology & Metabolism · 2020 · 19 citations · Full text

Medicine, Endocrinology, Gynecology +16